Haura EB - Search Results

1

Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.

Haura EB, Tanvetyanon T, Chiappori A, Williams C, Simon G, Antonia S, Gray J, Litschauer S, Tetteh L, Neuger A, Song L, Rawal B, Schell MJ, Bepler G. Haura EB, et al. J Clin Oncol. 2010 Mar 10;28(8):1387-94. doi: 10.1200/JCO.2009.25.4029. Epub 2010 Feb 8. J Clin Oncol. 2010. PMID: 20142592 Free PMC article. Clinical Trial.

2

Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.

Haura EB. Haura EB. Cancer Control. 2001 Jul-Aug;8(4):326-36. doi: 10.1177/107327480100800404. Cancer Control. 2001. PMID: 11483886 Free article. Review.

3

Direct repression of the Mcl-1 promoter by E2F1.

Croxton R, Ma Y, Song L, Haura EB, Cress WD. Croxton R, et al. Among authors: haura eb. Oncogene. 2002 Feb 21;21(9):1359-69. doi: 10.1038/sj.onc.1205157. Oncogene. 2002. PMID: 11857079

4

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Niu G, et al. Oncogene. 2002 Mar 27;21(13):2000-8. doi: 10.1038/sj.onc.1205260. Oncogene. 2002. PMID: 11960372

5

Management of advanced non-small cell lung cancer: current trends.

Haura EB. Haura EB. Curr Opin Pulm Med. 2002 Jul;8(4):251-6. doi: 10.1097/00063198-200207000-00002. Curr Opin Pulm Med. 2002. PMID: 12055385 Review.

6

Gene therapy for lung cancer. An introduction.

Haura EB, Sotomayor E, Antonia SJ. Haura EB, et al. Methods Mol Med. 2003;75:529-43. doi: 10.1385/1-59259-324-0:529. Methods Mol Med. 2003. PMID: 12407762 Review.

7

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Song L, Turkson J, Karras JG, Jove R, Haura EB. Song L, et al. Among authors: haura eb. Oncogene. 2003 Jul 3;22(27):4150-65. doi: 10.1038/sj.onc.1206479. Oncogene. 2003. PMID: 12833138

8

Gene therapy for lung cancer.

Haura EB, Sotomayor E, Antonia SJ. Haura EB, et al. Mol Biotechnol. 2003 Oct;25(2):139-48. doi: 10.1385/MB:25:2:139. Mol Biotechnol. 2003. PMID: 14526124 Review.

9

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

Simon GR, Ruckdeschel JC, Williams C, Cantor A, Chiappori A, Rocha Lima CM, Antonia S, Haura E, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Simon GR, et al. Cancer Control. 2003 Sep-Oct;10(5):388-95. doi: 10.1177/107327480301000506. Cancer Control. 2003. PMID: 14581894 Free article. Clinical Trial.

10

Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature.

D'Amato G, Rocha Lima C, Mahany JJ, Muro-Cacho C, Haura EB. D'Amato G, et al. Among authors: haura eb. Lung Cancer. 2004 Jun;44(3):381-90. doi: 10.1016/j.lungcan.2003.11.018. Lung Cancer. 2004. PMID: 15140552 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters